Methodhub Software has entered into a strategic partnership with Datafoundry, a leading provider of purpose-built AI/ML SaaS solutions for pharmacovigilance and life sciences. This collaboration is aimed at delivering end-to-end, technology-led Pharmacovigilance (PV) and pharma-tech solutions to global pharmaceutical, biotech, and life sciences enterprises.
With increasing regulatory scrutiny, rising drug safety expectations, and the growing complexity of global clinical and post-market data, PV has become a critical strategic function. Through this partnership, the company and Datafoundry will combine their complementary strengths to help organizations transition from fragmented, manual PV processes to intelligent, automated, and scalable safety operations.
The company will bring its strong capabilities in PV operations, regulatory compliance, and global delivery, while Datafoundry will contribute its advanced AI-powered solutions such as Safety AI, which is a End-to-end safety case management with intelligent automation, including case intake, triage, and compliance monitoring; Signal AI, which is AI-driven signal detection and risk management with faster identification of safety signals and reduced false positives; Literature Monitor, which is Automated global literature surveillance with AI-driven screening, extraction, and multilingual support.
Methodhub Software is engaged in offering IT and Consulting Services including Cloud Services, Data & AI Services, Cybersecurity, ERP/CRM Integration, IT Infrastructure, Recruitment Delivery Services and Combined Offerings to provide bespoke IT solutions supported by dedicated IT team to ensure continuous monitoring and support according to client’s specific needs.
| Company Name | CMP |
|---|---|
| TCS | 2057.50 |
| Infosys | 1042.40 |
| HCL Technologies | 1134.05 |
| Wipro | 174.30 |
| Tech Mahindra | 1405.90 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: